Xofluza Granule, For Suspension
Product Images NDC 50242-599
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Xofluza (NDC 50242-599). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Xofluza 02)
Figure A (Xofluza 03)
Figure B (Xofluza 04)
Figure C (Xofluza 05)
Figure D (Xofluza 06)
Figure E (Xofluza 07)
Figure F (Xofluza 08)
Figure G (Xofluza 09)
Figure H (Xofluza 10)
Figure I (Xofluza 11)
Principal Display Panel (40 mg/20 mL Bottle Carton)
Principal Display Panel (40 mg Tablet Blister Pack Carton)
Principal Display Panel (80 mg Tablet Blister Pack Carton)
Principal Display Panel (30 mg Packet Carton)
Principal Display Panel (40 mg Packet Carton)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.